RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase to Present at Global Investment Conference
We can get as philosophical as you want but the bottom line is that the market wouldn't be pricing a stock at 40 cents if investors truly believed that a company had the cure for cancer. It's that simple and no amount of window dressing can change the fact that this is an extremely risky junior stock where nothing should be presumed by investors. Figure it out. They hope to do on a shoe string budget what billions spent have failed to do so who's kidding who?